凯普生物：9月10日召开董事会会议

Group 1 - The company, Capbio (SZ 300639), held its sixth first temporary board meeting on September 10, 2025, in Chaozhou, Guangdong Province, to discuss the appointment of the head of the internal audit department among other documents [1] - For the first half of 2025, Capbio's revenue composition was as follows: molecular diagnostic products accounted for 67.65%, medical testing services for 29.07%, and medical service income for 3.27% [1] - As of the report date, Capbio's market capitalization was 3.8 billion yuan [1]